RT Journal Article
SR Electronic
T1 Risk of COVID-19 is associated with long-term exposure to air pollution
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.21.20073700
DO 10.1101/2020.04.21.20073700
A1 Huaiyu Tian
A1 Yonghong Liu
A1 Hongbin Song
A1 Chieh-Hsi Wu
A1 Bingying Li
A1 Moritz U.G. Kraemer
A1 Pai Zheng
A1 Xing Yan
A1 Guang Jia
A1 Yuxin Zheng
A1 Nils Chr. Stenseth
A1 Christopher Dye
YR 2020
UL http://medrxiv.org/content/early/2020/04/24/2020.04.21.20073700.abstract
AB High risk of severe disease of COVID-19 has been associated with patients with chronic obstructive pulmonary disease, cardiovascular disease or hypertension1, and long-term exposure to PM2.5 has been associated with COVID-19 mortality 2. We collate individual level data of confirmed COVID-19 cases during the first wave of the epidemic in mainland China by March 6, 2020. We pair these data with a mobile phone dataset, covering human movements from Wuhan before the travel ban and inner-city movements during the time of emergency response from 324 cities in China. Adjusting for socio-economic factors, an increase of 10 μg/m3 in NO2 or PM2.5 was found to be associated with a 22.41% (95%CI: 7.28%-39.89%) or 15.35% (95%CI: 5.60%-25.98%) increase in the number of COVID-19 cases, and a 19.20% (95%CI: 4.03%-36.59%) or 9.61% (95%CI: 0.12%-20.01%) increase in severe infection, respectively. Our results highlight the importance of air quality improvements to health benefits.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding for this study was provided by the National Natural Science Foundation of China (91643203, 81673234); Beijing Natural Science Foundation (JQ18025); Beijing Advanced Innovation Program for Land Surface Science; Young Elite Scientist Sponsorship Program by CAST (YESS)(2018QNRC001); H.T., M.U.G.K., and C.D. acknowledge support from the Oxford Martin School; HT acknowledges support from the Military Logistics Research Program. The funders had no role in study design, data collection and analysis, the decision to publish, or in preparation of the manuscript.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe used a well-tested research data platform that gathers nationwide human mobility, census data, air pollution data, smoking data from a nationwide survey, and socio-economic data.